Renalytix

RenalytixAI is a developer of artificial intelligence-enabled clinical diagnostic solutions for kidney health.

Business Model:

Revenue: $3M

Employees: 2-10

Detailed Renalytix Information

Geographic Data

Renalytix headquarters map

Address: 1460 Broadway

City: New York

State: NY

Zip: 10036

Country: US

Financial Info

Stage:

post ipo debt

Raised Last:

$21M

Raised Total:

$45M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

RenalytixAI is a developer of artificial intelligence (AI) enabled clinical diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions globally. RenalytixAI’s solutions are being designed to make significant improvements in kidney disease risk assessment, clinical care, and patient stratification for drug clinical trials. RenalytixAI’s technology platform will draw from distinct sources of patient data, including large electronic health records, predictive blood-based biomarkers, and other genomic information for analysis by learning computer algorithms. RenalytixAI intends to build a deep, unique pool of kidney disease-related data for different AI-enabled applications designed to improve predictive capability and clinical utility over time.

Contact Phone:
+18014472698

Contact Email:

Renalytix went public on 11/6/2018 on the London Stock Exchange

Listed Exchange:
London Stock Exchange

IPO Date:
11/6/2018

IPO Valuation:
$85M

Ticker Symbol:
RENX

IPO Price:
$1.5867562244119167/share

Amount Raised:
$33M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
4/2022 Post-IPO Debt 4 $21.2M Ann E. Berman
Christopher Mills
Thomas McLain
Timothy J. Scannell
Ann E. Berman
Christopher Mills
Thomas McLain
Timothy J. Scannell
1/2023 Grant 1 $10M Horizon Europe
Horizon Europe
2/2023 Private Placement $15.1M
4/2022 Post-IPO Debt $30M
7/2019 Post-IPO Equity $17.4M
11/2018 Series A $29M
4/2022 Post-IPO Equity 4 $8.8M Ann E. Berman
Christopher Mills
Thomas McLain
Timothy J. Scannell
Ann E. Berman
Christopher Mills
Thomas McLain
Timothy J. Scannell
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research